First Time Loading...

Infinity Pharmaceuticals Inc
NASDAQ:INFI

Watchlist Manager
Infinity Pharmaceuticals Inc Logo
Infinity Pharmaceuticals Inc
NASDAQ:INFI
Watchlist
Price: 0.0037 USD
Updated: Apr 29, 2024

Infinity Pharmaceuticals Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Infinity Pharmaceuticals Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Infinity Pharmaceuticals Inc
NASDAQ:INFI
Revenue
$2.6m
CAGR 3-Years
22%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.1B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
9%
Amgen Inc
NASDAQ:AMGN
Revenue
$28.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
20%

See Also

What is Infinity Pharmaceuticals Inc's Revenue?
Revenue
2.6m USD

Based on the financial report for Jun 30, 2023, Infinity Pharmaceuticals Inc's Revenue amounts to 2.6m USD.

What is Infinity Pharmaceuticals Inc's Revenue growth rate?
Revenue CAGR 5Y
-16%

Over the last year, the Revenue growth was 16%. The average annual Revenue growth rates for Infinity Pharmaceuticals Inc have been 22% over the past three years , -16% over the past five years .